Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: A synergistic drug combination

Clinical Infectious Diseases

Volumn 27, Issue 6, 1998, Pages 1554-1556

  Matsumura, Samuel ^b   Simor, Andrew E ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

AGED; ANOREXIA; ANTIBIOTIC RESISTANCE; AORTA STENOSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; CASE REPORT; CHILL; CLINICAL FEATURE; DRUG MIXTURE; DRUG POTENTIATION; ENTEROCOCCUS FAECIUM; FEVER; HEART MURMUR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0032450891     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517755     Document Type: Article

References (8)

1. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 4th ed. NCCLS document M7-A4. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
2. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents: tentative guideline. NCCLS document M26-T. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1992.
3. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33:24-7.
4. Vijayvargiya R, Veis JH. Antibiotic-resistant endocarditis in a hemodialysis patient. J Am Soc Nephrol 1996; 7:536-42.
5. Furlong WB, Rakowski TA. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns. Clin Infect Dis 1997; 25:163-4.
6. Moellering RC Jr. Vancomycin-resistant enterococci. Clin Infect Dis 1998; 26:1196-9.
7. Brumfitt W, Hamilton-Miller JMT, Shah S. In vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria. J Antimicrob Chemother 1992; 30(suppl A):29-37.
8. Griswold MW, Lomaestro BM, Briceland LL. Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination. American Journal of Health-System Pharmacists 1996; 53:2045-53.